Search results for "DVT"


 
Results 21 - 30 of about 79 for "DVT".
Sort by: Relevance | Newest | Oldest

Dabigatran noninferior to warfarin for preventing VTE recurrence

In patients who had a previous venous thromboembolism (VTE), dabigatran prevented recurrence about as well as warfarin and caused fewer bleeding events, according to two new manufacturer-sponsored trials of extended treatment.
https://immattersacp.org/weekly/archives/2013/02/26/5.htm
26 Feb 2013

Oral anticoagulants and antiplatelets compared for risk of recurrent VTE, major bleeds

All oral anticoagulants and antiplatelet agents reduced recurrence of venous thromboembolism (VTE) compared with placebo, with aspirin reducing risk the least and vitamin K antagonists reducing it the most, a meta-analysis found.
https://immattersacp.org/weekly/archives/2013/09/10/5.htm
10 Sep 2013

Age-adapted D-dimer cutoffs in older patients may help exclude DVT in primary care

Using age-adapted D-dimer cutoffs in older patients may help rule out deep venous thrombosis (DVT) in primary care, according to a new study.
https://immattersacp.org/weekly/archives/2012/06/12/6.htm
12 Jun 2012

Aspirin may be noninferior to dalteparin for VTE prophylaxis following hip replacements

Aspirin therapy for 28 days may be a reasonable alternative to low-molecular-weight heparin for extended venous thromboembolism (VTE) prophylaxis among hip replacement patients who have already received low-molecular-weight heparin for 10 days, a study found.
https://immattersacp.org/weekly/archives/2013/06/04/5.htm
4 Jun 2013

New model predicts future risk of VTE

Researchers have devised a new algorithm to predict a patient's risk of developing venous thromboembolism in the next five years, based on simple clinical variables.
https://immattersacp.org/weekly/archives/2011/08/23/4.htm
23 Aug 2011

Aspirin appears to reduce recurrence of VTE after stopping anticoagulants

Aspirin reduced the risk of venous thromboembolism (VTE) recurrence with no apparent increase in major bleeding in patients who had an initial unprovoked VTE and had discontinued anticoagulant treatment, a study found.
https://immattersacp.org/weekly/archives/2012/06/05/6.htm
5 Jun 2012

MKSAP Quiz: Evaluation for right calf pain

A 24-year-old woman is evaluated for pain in the right calf since yesterday. She reports no shortness of breath, cough, or chest pain. Her medical history is unremarkable. Following a physical exam and ultrasound, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2023/07/04/3.htm
4 Jul 2023

Major bleeding, mortality risks after VTE similar on DOACs or warfarin

The risk of major bleeding and of death was similar for patients taking direct oral anticoagulants compared to those taking warfarin.
https://immattersacp.org/weekly/archives/2017/10/24/4.htm
24 Oct 2017

Aspirin didn't reduce recurrent VTE but did reduce major vascular events

Low-dose aspirin may have therapeutic benefit for patients who have completed initial anticoagulant therapy for an unprovoked venous thromboembolism (VTE) even though the rate of recurrent VTE was not significantly reduced in a recent study.
https://immattersacp.org/weekly/archives/2012/11/13/1.htm
13 Nov 2012

Apixaban shows superior effectiveness, safety compared to rivaroxaban

For patients with venous thromboembolism, initiation of apixaban was associated with lower rates of recurrence and intracranial and gastrointestinal bleeding than rivaroxaban in a population-based cohort study.
https://immattersacp.org/weekly/archives/2021/12/07/2.htm
7 Dec 2021

Result Page: Prev   1   2   3   4   5   6   7   8   Next